Medical/Pharmaceuticals
CSafe Expands Executive Team with Chief Financial Officer
Seasoned financial leader, Anthony Pishotti, joins CSafe executive team to further drive the company's portfolio and geographic growth. MONROE, Ohio, Sept. 12, 2023 /PRNewswire/ -- CSafe, the largest active and passive temperature-controlled shipping solutions provider for the biopharmaceutical ...
2023-09-12 20:59
2188
Datasea Announces Pricing of $2.0 Million Underwritten Public Offering
BEIJING, Sept. 12, 2023 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada incorporated digital technology corporation engaged in converging and innovative business segments for intelligent acoustics and 5G messaging technology inChina, today announced the pricing ...
2023-09-12 20:30
4293
Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration
CASTRES, France and BASEL, Switzerland, Sept. 12, 2023 /PRNewswire/ --
Pierre Fabre Laboratories
2023-09-12 20:00
1546
New South Wales Government (NSW) Partner, Myeloid Therapeutics, Initiates Patient Dosing with MT-302 in Phase 1 Study at Clinical Site in Australia
NSW and Myeloid entered into a partnership in February 2023 to launch state-of-the-art GMP manufacturing RNA facility CAMBRIDGE, Mass., Sept. 12, 2023 /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage oncology company, has dosed the first patient with MT-302 in a Phase 1 s...
2023-09-12 20:00
1092
Metabolon Launches New Biological Stress Discovery Panel to Aid Detection of Inflammation and Biological Stress Biomarkers
Metabolon's new Biological Stress Discovery Panel supports inflammation, immune function, and stress research with advanced analytics MORRISVILLE, N.C., Sept. 12, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, di...
2023-09-12 19:57
1162
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius' novel anti-PD-1 mAb HANSIZHUANG in MENA
* HANSIZHUANG's coverage footprint includes 22 emerging market countries acrossSoutheast Asia and MENA – * KGbio to develop and commercialise HANSIZHUANG in 12 MENA countries; Henlius to receiveUS$7 million upfront payment plus royalties and up to US$8 million in regulatory milestone payments...
2023-09-12 19:24
1477
The Korean Society of Ginseng confirms the effects of consuming red ginseng in the prevention and improvement of dementia
- Through the study "Elucidation of Mechanisms for Dementia Prevention and Improvement by Red Ginseng" SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- Through continuous research, the secrets of ginseng, a representative medicinal herb of Korea, are being revealed, showcasing its efficacy. Re...
2023-09-12 17:00
2071
Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening
* Lunit's collaborative study supports AI as a viable alternative to one human reader inEurope's double reading system - published in The Lancet Digital Health SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagno...
2023-09-12 13:03
2167
Genesis MedTech introduces China's first domestic brand of NPMA-approved antibacterial sutures
SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced that its absorbable sutures with antibacterial protection have successfully obtained approval from theChina's National Medical Products Administration (NMPA) for market release. The newly...
2023-09-12 07:00
1482
Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening
- Lunit's collaborative study supports AI as a viable alternative to one human reader inEurope's double reading system - published in The Lancet Digital Health SEOUL, South Korea, Sept. 11, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnosti...
2023-09-11 21:00
1810
MGI Launches the DCS Lab Initiative to Expand Global Omics Access and Capabilities
SHENZHEN, China, Sept. 11, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced the DCS Lab Initiative to help facilitate large-scale leading multi-omics laboratories and spur critical scientific research. Under the initiative, ...
2023-09-11 19:43
1177
IPMG Drives Health Transformation and Strengthens Indonesia's Economy Through Efforts to Accelerate Access to Innovative Medicines and Vaccines, also Partnerships
JAKARTA, Indonesia, Sept. 11, 2023 /PRNewswire/ -- The research and development-based multinational pharmaceutical industry association, the International Pharmaceutical Manufacturers Group (IPMG) is always committed to supporting and encouraging advocacy and transformation of Government policie...
2023-09-11 18:52
2102
Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer
AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment ofSaulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience...
2023-09-11 15:00
1265
Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer
AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment ofSaulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience...
2023-09-11 15:00
1354
Can we really make a difference in reducing the heartbreak of millions of miscarriages each year?
ADELAIDE, Australia, Sept. 11, 2023 /PRNewswire/ -- Globally, one in six pregnancies end in miscarriage, which is generally defined as the loss of an intrauterine pregnancy before viability. This equates to an estimated 23 million miscarriages every year, or over 40 miscarriages per minute. Th...
2023-09-11 14:58
1621
Biosyngen received FDA approval for Phase I/II Clinical Trials for BRL03, targeting Lung Cancer, Gastric Cancer and other advanced Solid Tumors
SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- On September 9th, 2023, Biosyngen Pte Ltd (hereafter as "Biosyngen") announced that the U.S. FDA has cleared the Investigational New Drug (IND) application for Phase I/II clinical trial ofBRL03 for the treatment of lung cancer, gastric cancer and other ad...
2023-09-11 14:53
1475
PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells)
IRVINE, Calif., Sept. 11, 2023 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first dose cohort of its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma (r/r B-NHL) clinical ...
2023-09-11 12:05
2274
Kidney Dialysis Foundation Unveils First In-Person 'Got To Walk 2023: Illuminating Life' Event To Raise Funds For Needy Kidney Patients
Illuminating the lives of needy kidney patients by walking together for a good cause. SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- The Kidney Dialysis Foundation (KDF) is thrilled to unveil the inaugural in-person edition of the 'Got To Walk 2023: Illuminating Life' walkathon, a flagship fundra...
2023-09-11 09:00
1416
Introducing BIOSTAR® cutting-edge Conventional TBNA (cTBNA) and Endobronchial ultrasound (EBUS) TBNA (EBUS-TBNA) needle: Revolutionizing Minimally Invasive Diagnostic techniques
SAN JOSE, Calif., Sept. 9, 2023 /PRNewswire/ -- In a remarkable stride towards advancing medical technology, we are thrilled to announce the launch of our groundbreaking BioStar® Transbronchial Aspiration Needle (TBNA) designed to transform the landscape of minimally invasive diagnostics. This in...
2023-09-09 01:30
2716
Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept® S DSM 50 μm
Sirtex partners with Magle Group to advance the international treatment of liver and lung cancer WOBURN, Mass., Sept. 8, 2023 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of interventional treatment solutions, announced today the establishment of a collaboration and exclusiv...
2023-09-08 22:45
2262
Week's Top Stories
Most Reposted
Agoda releases generative AI film to capture the joy of travel
[Picked up by 348 media titles]
2024-12-10 10:00
Singapore's IMAGINE AI: Largest Global Gathering to Shape the Future of Healthcare with AI Innovations
[Picked up by 316 media titles]
2024-12-06 10:41
Mastercard Economics Institute: APAC growth expected to hold steady in 2025; global policy resets may see shift in gears
[Picked up by 313 media titles]
2024-12-10 09:00Building Asia's Future: Omni HR Secures $7.4mn for HR Tech Expansion
[Picked up by 306 media titles]
2024-12-09 10:00
CCTV+: Yuhang Journey ǀ Follow Olivier to Explore Ancient Liangzhu and Savor Jingshan Tea
[Picked up by 283 media titles]
2024-12-08 20:07Most Read
Singapore's IMAGINE AI: Largest Global Gathering to Shape the Future of Healthcare with AI Innovations
2024-12-06 10:41
6978
Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations
2024-12-06 20:15
6547
BROOKLYN NETS AND PHOENIX SUNS TO PLAY TWO PRESEASON GAMES IN MACAO IN OCTOBER 2025
2024-12-06 21:09
5775
